会社概要
- 正式社名: Shenzhen JYMed Technology Co., Ltd.
- 登録国: China
- 住所: GuangdongShenzhen2-408, No. 10, Gaoxin Middle Road, Nanshan District, Shenzhen • Guangdong
説明:
Founded in 2009, Shenzhen JYMed Technology has spent 17 years building a world-leading peptide platform, now employing over 600 staff including a 130-plus-member senior R&D team across a 7,000-square-meter R&D center and two manufacturing bases. Its API manufacturing site has twice passed on-site US FDA audits, and the company offers more than 20 peptide APIs — including semaglutide, tirzepatide, leuprolide acetate, bivalirudin, goserelin acetate, and oxytocin — with over 10 products carrying completed US DMF filings, alongside cosmetic peptides such as acetyl hexapeptide-8 and copper peptide. With peptide API capacity exceeding 10 tons annually and formulation capacity above 30 million vials, JYMed provides end-to-end CRO, CMO, and CDMO services from custom synthesis through commercial-scale production, serving markets across North America, Europe, Asia, the Middle East, and Africa.
事業活動
原薬(API)
製造業者サービスプロバイダー輸出業者
完成医薬品(製剤)
製造業者サービスプロバイダー輸出業者
販売市場
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
主要製品/サービス
- 原薬(API): Oxytocin, Buserelin Acetate, Triptorelin Acetate, Deslorelin Acetate, Alarelin, Liraglutide, Peptides, Semaglutide, Cetrorelix Acetate, Leuprolide Acetate, Oxytocin Acetate, Terlipressin Acetate, Goserelin Acetate, Leuprorelin Acetate, Desmopressin Acetate, Exenatide Acetate, Carbetocin Acetate, Atosiban Acetate, Somatostatin Acetate, Bivalirudin, Pramlintide Acetate, Thymopentin, Bivalirudin Trifluoroacetate, Eptifibatide Acetate, Atosiban, Calcitonin (salmon), 50-56-6/ oxytocin acetate, Angiotensin II, aviptadil, AVIPTADIL ACETATE, Buserelin-amino acids and derivatives, Cetrorelix, Elcatonin Acetate-peptides, Enfuvirtide-peptides, Eptifibatide-peptides, Exenatide-peptides, Fertirelin Acetate-peptides, GLP-1 (7-36) amide Acetate-peptides, Glucagon-peptides, Gonadorelin-peptides, GUK-Cu, Histrelin Acetate-peptides, Liraglutide Acetate, Thymalfasin
当社の製品・サービス
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
認証
DMF filings
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す